655 Bidirectional Gut-Skin Axis
(86) Thompson KG, Rainer BM, Antonescu C, et al. Comparison of the skin microbiota in acne and rosacea.
Exp Dermatol. 2021 30(10):1375–1380. doi:10.1111/exd.14098
(87) Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol
Pract Concept. 2017 7(4):31–37. doi:10.5826/dpc.0704a08
(88) Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology.
1995 191(1):6–8. doi:10.1159/000246470
(89) Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness
of its eradication. Clin Gastroenterol Hepatol. 2008 6(7):759–764. doi:10.1016/j.cgh.2008.02.054
(90) Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders:
A population-based cohort study. Br J Dermatol. 2017 176(1):100–106. doi:10.1111/bjd.14930
(91) Nam J-H, Yun Y, Kim H-S, et al. Rosacea and its association with enteral microbiota in Korean females.
Exp Dermatol. 2018 27(1):37–42. doi:10.1111/exd.13398
(92) Szántó M, Dózsa A, Antal D, Szabó K, Kemény L, Bai P. Targeting the gut-skin axis—probiotics as new
tools for skin disorder management? Exp Dermatol. 2019 28(11):1210–1218. doi:10.1111/exd.14016
(93) Vargason AM, Anselmo AC. Live biotherapeutic products and probiotics for the skin. Adv Nanobiomed
Res. October 2021 1(12). doi:10.1002/anbr.202100118
(94) FDA. Early Clinical Trials with Live Biotherapeutic Products: Chemistry, Manufacturing, and Control
Information Guidance for Industry, Tech. Rep. Cent. Biol. Eval. Res. 2016:1–17.
(95) Ağagündüz D, Gençer Bingöl F, Çelik E, et al. Recent developments in the probiotics as live biotherapeutic
products (LBPs) as modulators of gut brain axis related neurological conditions. J Transl Med. October
2022 20(1):460. doi:10.1186/s12967-022-03609-y
(96) Rutter JW, Dekker L, Owen KA, Barnes CP. Microbiome engineering: engineered live biotherapeutic
products for treating human disease. Front Bioeng Biotechnol. September 2022 10:1000873. doi:10.3389/
fbioe.2022.1000873
(97) De Almeida CV, Antiga E, Lulli M. Oral and topical probiotics and postbiotics in skincare and
dermatological therapy: A concise review. Microorganisms. May 2023 11(6). doi:10.3390/microor​ganisms​
11061420
(98) Roslan MAM, Omar MN, Sharif NAM, et al. Recent advances in single-cell engineered live biotherapeutic
products research for skin repair and disease treatment. npj Biofilms Microbiomes. December 2023 9(1):95.
doi:10.1038/s41522-023-00463-8
(99) Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus
exposure. Clin Exp Allergy. 2015 45(4):779–787. doi:10.1111/cea.12489
(100) Han Y, Kim B, Ban J, et al. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment
of atopic dermatitis. Pediatr Allergy Immunol. 2012 23(7):667–673. doi:10.1111/pai.12010
(101) Woo S-I, Kim J-Y, Lee Y-J, Kim N-S, Hahn Y-S. Effect of Lactobacillus sakei supplementation in
children with atopic eczema-dermatitis syndrome. Ann Allergy Asthma Immunol. 2010 104(4):343–348.
doi:10.1016/j.anai.2010.01.020
(102) Huang R, Ning H, Shen M, Li J, Zhang J, Chen X. Probiotics for the treatment of atopic dermatitis
in children: A systematic review and meta-analysis of randomized controlled trials. Front Cell Infect
Microbiol. September 2017 7:392. doi:10.3389/fcimb.2017.00392
(103) Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic
disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003 361(9372):1869–1871.
doi:10.1016/S0140-6736(03)13490-3
(104) Navarro-López V, Ramírez-Boscá A, Ramón-Vidal D, et al. Effect of oral administration of a mixture
of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate
atopic dermatitis: A randomized clinical trial. JAMA Dermatol. 2018 154(1):37–43. doi:10.1001/jamader​
matol.2017.3647
(105) Kwon M-S, Lim SK, Jang J-Y, et al. Lactobacillus sakei WIKIM30 ameliorates atopic dermatitis-like
skin lesions by inducing regulatory T cells and altering gut microbiota structure in mice. Front Immunol.
August 2018 9:1905. doi:10.3389/fimmu.2018.01905

656 JOURNAL OF COSMETIC SCIENCE
(106) Kim W-K, Jang YJ, Han DH, et al. Administration of Lactobacillus fermentum KBL375 causes
taxonomic and functional changes in gut microbiota leading to improvement of atopic dermatitis. Front
Mol Biosci. September 2019 6:92. doi:10.3389/fmolb.2019.00092
(107) Lim SK, Kwon M-S, Lee J, et al. Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin
lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice. Sci Rep. January
2017 7:40040. doi:10.1038/srep40040
(108) Fabbrocini G, Bertona M, Picazo Ó, Pareja-Galeano H, Monfrecola G, Emanuele E. Supplementation
with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling
and improves adult acne. Benef Microbes. 2016 7(5):625–630. doi:10.3920/BM2016.0089
(109) Nagpal R, Wang S, Ahmadi S, et al. Human-origin probiotic cocktail increases short-chain fatty
acid production via modulation of mice and human gut microbiome. Sci Rep. August 2018 8(1):12649.
doi:10.1038/s41598-018-30114-4
(110) Rybak I, Haas KN, Dhaliwal SK, et al. Prospective placebo-controlled assessment of spore-based
probiotic supplementation on sebum production, skin barrier function, and acne. J Clin Med. January
2023 12(3). doi:10.3390/jcm12030895
(111) Jung GW, Tse JE, Guiha I, Rao J. Prospective, randomized, open-label trial comparing the safety,
efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement
and minocycline in subjects with mild to moderate acne. J Cutan Med Surg. 2013 17(2):114–122.
doi:10.2310/7750.2012.12026
(112) Kwon H-K, Lee C-G, So J-S, et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells
by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A. 2010 107(5):2159–
2164. doi:10.1073/pnas.0904055107
(113) Fu Y-R, Yi Z-J, Pei JL, Guan S. Effects of Bifidobacterium bifidum on adaptive immune senescence in
aging mice. Microbiol Immunol. 2010 54(10):578–583. doi:10.1111/j.1348-0421.2010.00255.x
(114) Hacini-Rachinel F, Gheit H, Le Luduec J-B, Dif F, Nancey S, Kaiserlian D. Oral probiotic control skin
inflammation by acting on both effector and regulatory T cells. PLOS ONE. March 2009 4(3):e4903.
doi:10.1371/journal.pone.0004903
(115) Cazzola M, Tompkins TA, Matera MG. Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2
models of infection. Ther Adv Respir Dis. 2010 4(5):259–270. doi:10.1177/1753465810379009
(116) Glück U, Gebbers J-O. Ingested probiotics reduce nasal colonization with pathogenic bacteria
(Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr.
2003 77(2):517–520. doi:10.1093/ajcn/77.2.517
(117) Manzhalii E, Hornuss D, Stremmel W. Intestinal-borne dermatoses significantly improved by oral
application of Escherichia coli Nissle 1917. World J Gastroenterol. 2016 22(23):5415–5421. doi:10.3748/
wjg.v22.i23.5415
(118) Buianova I, Girnyk G, Senyshyn N, Hepburn IS. Gut-skin connection: role of intestinal biome in rosacea.
Off J Am Coll Gastroenterol ACG. October 2018 113(suppl). doi:10.14309/00000434-201810001-00216
(119) Fortuna MC, Garelli V, Pranteda G, et al. A case of scalp rosacea treated with low dose doxycycline
and probiotic therapy and literature review on therapeutic options. Dermatol Ther. 2016 29(4):249–251.
doi:10.1111/dth.12355
(120) Dini I, Laneri S. Nutricosmetics: A brief overview. Phytother Res. 2019 33(12):3054–3063. doi:10.1002/
ptr.6494
(121) Aguilar-Toalá JE, Vidal-Limon A, Liceaga AM. Nutricosmetics: A new frontier in bioactive peptides’
research toward skin aging. Adv Food Nutr Res. 2023 104:205–228. doi:10.1016/bs.afnr.2022.10.002
(122) Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: the relationship between intestinal
bacteria and skin health. World J Dermatol. 2017 6(4):52–58. doi:10.5314/wjd.v6.i4.52
(123) Lee E-S, Song E-J, Nam Y-D, Lee S-Y. Probiotics in human health and disease: from nutribiotics to
pharmabiotics. J Microbiol. 2018 56(11):773–782. doi:10.1007/s12275-018-8293-y
(124) Gao T, Wang X, Li Y, Ren F. The role of probiotics in skin health and related gut-skin axis: a review.
Nutrients. July 2023 15(14). doi:10.3390/nu15143123